The Prostate Immobilization Device Study

Status Completed

Clinical Trial Summary

The purpose of this study is to compare reproducibility of the device position and location of the prostate rectum interface between two immobilization devices for radiation therapy of prostate carcinoma.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01408706
Study type	Interventional
Source	Wheaton Franciscan Healthcare
Contact
Status	Completed
Phase	N/A
Start date	August 2011
Completion date	October 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02217709` - Phenelzine Sulfate in Treating Patients With Non-metastatic Recurrent Prostate Cancer	Phase 2
Completed	`NCT03077659` - Trial of NanoPac® Focal Therapy in Subjects With Prostate Cancer	Phase 2
Active, not recruiting	`NCT03624660` - Dose-Escalated Proton Radiation Therapy for High-Risk Prostate Cancer	N/A
Completed	`NCT01054079` - Cinacalcet Hydrochloride in Treating Men With Recurrent Prostate Cancer	Phase 2
Terminated	`NCT00512668` - Hormone Therapy and Temsirolimus in Treating Patients With Relapsed Prostate Cancer	Phase 1
Completed	`NCT00087139` - Ixabepilone in Treating Patients With Metastatic Prostate Cancer	Phase 2
Completed	`NCT00182052` - Rosiglitazone (Avandia) vs. Placebo for Androgen Dependent Prostate Cancer	Phase 3
Active, not recruiting	`NCT03511196` - Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer	Early Phase 1
Active, not recruiting	`NCT01655836` - High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer	Phase 1
Terminated	`NCT03535675` - Muscadine Plus (MPX) In Men With Prostate Cancer	Phase 3
Terminated	`NCT01866423` - Orteronel in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer	Phase 2
Completed	`NCT02234921` - Pilot Study of DRibble Vaccine for Prostate Cancer Patients	Phase 1
Completed	`NCT01468532` - Docetaxel, Prednisone, and Pasireotide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer	Phase 1/Phase 2
Active, not recruiting	`NCT03686683` - Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer	Phase 3
Active, not recruiting	`NCT03689699` - Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8)	Phase 1/Phase 2
Recruiting	`NCT04694924` - Prospective Prostate Cancer and Patient-reported Outcomes Registry
Active, not recruiting	`NCT04909294` - Evaluation of the Efficacy and the Safety of a Stereotaxic Prostatic Radiotherapy Delivered With Linac MRI, in Patients With Prostate Adenocarcinoma	N/A
Completed	`NCT02225925` - Intraoperative Dosimetry for Prostate Brachytherapy Using Fluoroscopy and Ultrasound	N/A
Completed	`NCT01949519` - Docetaxel and Lycopene in Metastatic Prostate Cancer	Phase 1
Completed	`NCT01433913` - Metformin Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery	Phase 2